文献速递血管炎

真实临床实践中ANCA检测的诊断性能与预测价值:西班牙队列研究

ANCA testing in real-world clinical practice: diagnostic performance and predictive value in a Spanish cohort.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该回顾性研究纳入西班牙某三级医院4年内5157例申请ANCA检测的患者,评估IIF检测对GPA和MPA的诊断性能。结果显示IIF敏感性93%、特异性88%、阴性预测值99.9%、阳性预测值仅6.1%,限制于典型核型或联合CLIA阳性>20 IU/ml时特异性提高。

要点

  • IIF检测ANCA对GPA/MPA阴性预测值高达99.9%,适合排除诊断。
  • IIF阳性预测值仅6.1%,非特异症状检测时阳性结果解读需谨慎。
  • 联合典型核型或CLIA>20 IU/ml可显著提高特异性至96.8%–99.6%。

核心结论

  • ANCA IIF对GPA和MPA保持良好诊断效率及极高阴性预测值,但阳性预测值低,尤其用于非特异症状时。

研究设计与样本

  • 回顾性研究纳入西班牙某三级医院4年内所有申请ANCA检测的患者,共5157例,IIF阳性血清进一步用CLIA检测抗PR3和抗MPO抗体。

主要发现

  • IIF阳性653例(12.7%),其中P-ANCA占17.9%、C-ANCA占13.3%、A-ANCA占68.8%。
  • A-ANCA中CLIA阴性占97.3%;共诊断AAV 47例,其中42例(89.4%)IIF阳性。
  • IIF对GPA和MPA的敏感性93%、特异性88%、NPV 99.9%、PPV 6.1%。
  • 几乎所有AAV病例诊断于高验前概率患者(如肾脏病、肺部浸润或周围神经病),间质性肺病是IIF阳性患者中最常见的非AAV诊断。

关键数值与推荐

  • 限制于典型核型(C-ANCA或P-ANCA)时特异性为96.8%。
  • 联合CLIA阳性结果>20 IU/ml时特异性为99.6%。

临床怎么用

  • IIF阴性对GPA/MPA有极强排除价值,高验前概率患者应结合临床表现解读。
  • IIF阳性尤其非典型核型时需CLIA确认,低验前概率下阳性预测值低,避免过度诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: ANCA are a key biomarker for ANCA-associated vasculitis (AAV), particularly microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA). Although indirect immunofluorescence (IIF) has traditionally been the reference technique, its diagnostic value in contemporary real-world practice remains uncertain. The aim of this study was to evaluate the diagnostic performance of IIF ANCA testing in routine clinical practice. METHODS: We conducted a retrospective study of all patients with an ANCA request at a tertiary hospital over a 4-year period. All IIF-positive sera were subsequently tested for anti-PR3 and anti-MPO antibodies by chemiluminescent immunoassay (CLIA). Clinical data, test indication and final diagnoses were retrieved from electronic medical records. RESULTS: We included 5157 patients and IIF was positive in 653 (12.7%): perinuclear ANCA (P-ANCA) in 17.9%, cytoplasmic ANCA (C-ANCA) in 13.3% and atypical ANCA (A-ANCA) in 68.8%. CLIA was negative in 97.3% of A-ANCA. AAV was diagnosed in 47 patients, and 42 (89.4%) had positive IIF. For GPA and MPA, IIF showed a sensitivity of 93% and specificity of 88%, with a very high negative predictive value (NPV) (99.9%) but low positive predictive value (PPV) (6.1%). Specificity improved to 96.8% when restricted to typical patterns (C-ANCA or P-ANCA) and to 99.6% when combined with positive CLIA results >20 IU/ml. Almost all AAV cases were diagnosed in patients with high pre-test probability (such as renal disease, lung infiltrates or peripheral neuropathies) and interstitial lung disease was the most frequent non-AAV diagnosis in IIF-positive patients. CONCLUSIONS: ANCA IIF retains good diagnostic efficiency and a very high NPV for GPA and MPA, but has low PPV, particularly when tested for nonspecific symptoms.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Loureiro-Amigo J, Mestre-Torres J, Marín-Sánchez A, et al. ANCA testing in real-world clinical practice: diagnostic performance and predictive value in a Spanish cohort. Rheumatology (Oxford). 2026. PMID: 41649468. doi:10.1093/rheumatology/keag072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。